Differential effect of etanercept on cutaneous and joint lesions in psoriatic arthritis

被引：0

作者：

Mizote, Yukihiro ^{[1
]}

Nakahara, Takeshi ^{[1
]}

Mitoma, Chikage ^{[1
]}

Nakao, Masayoshi ^{[1
]}

Mitoma, Hiroki ^{[2
]}

Moroi, Yoichi ^{[1
]}

Furue, Masutaka ^{[1
]}

机构：

[1] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka 812, Japan

[2] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan

来源：

JOURNAL OF DERMATOLOGY | 2012年 / 39卷 / 03期

关键词：

ALPHA; THERAPY; TNF;

D O I：

10.1111/j.1346-8138.2011.01267.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：284 / 285

页数：2

共 10 条

[1]

Aeberli D, 2002, SWISS MED WKLY, V132, P414

[2] Etanercept provides a more physiological approach in the treatment of psoriasis [J].

Altomare, Gianfranco ;

Ayala, Fabio ;

Berardesca, Enzo ;

Chimenti, Sergio ;

Giannetti, Alberto ;

Girolomoni, Giampiero ;

Lotti, Torello ;

Martini, Patrizia ;

Peserico, Andrea ;

Guerra, Antonio Puglisi ;

Vena, Gino A. .

DERMATOLOGIC THERAPY, 2008, 21 :S1-S14

[3] Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: A literature review and potential mechanisms of action [J].

Collamer, Angelique N. ;

Guerrero, Karen T. ;

Henning, Jeffery S. ;

Battafarano, Daniel F. .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (07) :996-1001

[4] Psoriasis and pustular dermatitis triggered by TNF-α inhibitors in patients with rheumatologic conditions [J].

de Gannes, Gillian C. ;

Ghoreishi, Mchran ;

Pope, Janet ;

Russell, Anthony ;

Bell, David ;

Adams, Stewart ;

Shojania, Kamran ;

Martinka, Magdalena ;

Dutz, Jan P. .

ARCHIVES OF DERMATOLOGY, 2007, 143 (02) :223-231

[5] Tumor Necrosis Factor α Blockade Exacerbates Murine Psoriasis-like Disease by Enhancing Th17 Function and Decreasing Expansion of Treg Cells [J].

Ma, Hak-Ling ;

Napierata, Lee ;

Stedman, Nancy ;

Benoit, Stephen ;

Collins, Mary ;

Nickerson-Nutter, Cheryl ;

Young, Deborah A. .

ARTHRITIS AND RHEUMATISM, 2010, 62 (02) :430-440

[6] Long-term experience with etanercept in psoriatic arthritis patients: A 3-year observational study [J].

Mazzotta, Annamaria ;

Esposito, Maria ;

Schipani, Caterina ;

Chimenti, Sergio .

JOURNAL OF DERMATOLOGICAL TREATMENT, 2009, 20 (06) :354-358

[7] Cross-regulation of TNF and IFN-α in autoimmune diseases [J].

Palucka, AK ;

Blanck, JP ;

Bennett, L ;

Pascual, V ;

Banchereau, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (09) :3372-3377

[8] Cytokine imbalance with increased production of interferon-α in psoriasiform eruptions associated with antitumour necrosis factor-α treatments [J].

Seneschal, J. ;

Milpied, B. ;

Vergier, B. ;

Lepreux, S. ;

Schaeverbeke, T. ;

Taieb, A. .

BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 (05) :1081-1088

[9] Psoriasis induced by anti-tumor necrosis factor therapy - A paradoxical adverse reaction [J].

Sfikakis, PP ;

Iliopoulos, A ;

Elezoglou, A ;

Kittas, C ;

Stratigos, A .

ARTHRITIS AND RHEUMATISM, 2005, 52 (08) :2513-2518

[10] Classification criteria for psoriatic arthritis - Development of new criteria from a large international study [J].

Taylor, William ;

Gladman, Dafna ;

Helliwell, Philip ;

Marchesoni, Antonio ;

Mease, Philip ;

Mielants, Herman .

ARTHRITIS AND RHEUMATISM, 2006, 54 (08) :2665-2673

← 1 →